NIH Analyzes “Interactive Treatment” For Relief Of Chronic Pain And Focuses On Re-ducing Opioid Misuse; Electromedical Technologies, Inc.’s (OTCQB: EMED) Devices Deliver Non-Opioid Relief From Acute And Chronic Pain
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

NIH Analyzes “Interactive Treatment” For Relief Of Chronic Pain And Focuses On Re-ducing Opioid Misuse; Electromedical Technologies, Inc.’s (OTCQB: EMED) Devices Deliver Non-Opioid Relief From Acute And Chronic Pain

In its own publication, NIH Medline Plus Magazine, the National Institutes of Health (NIH) published an analysis of pain management titled, “From Opioids To Mindfulness: A New Approach To Chronic [...]

READ MORE
Non-Invasive Neuromodulation Once Seen As “Futuristic” Now Seen Offering Effective Treat-ment For Acute Pain; Electromedical Technologies, Inc.’s (OTCQB: EMED) Devices Of-fer Relief For Patients With Chronic And Acute Pain
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

Non-Invasive Neuromodulation Once Seen As “Futuristic” Now Seen Offering Effective Treat-ment For Acute Pain; Electromedical Technologies, Inc.’s (OTCQB: EMED) Devices Of-fer Relief For Patients With Chronic And Acute Pain

The medical community is seeking to deliver acute pain and chronic pain management in numerous ways. Most recently, a medical review of ‘neuromodulation’ said the treatment was once seen as only [...]

READ MORE
Medical Cannabis As A Reliever To Chronic Pain Is Seen As One Alternative To Addictive Opi-oids, According to New Research Study; Electromedical Technologies, Inc.’s (OTCQB: EMED) Devices Offer FDA Cleared Treatment For Acute Pain
By
In NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

Medical Cannabis As A Reliever To Chronic Pain Is Seen As One Alternative To Addictive Opi-oids, According to New Research Study; Electromedical Technologies, Inc.’s (OTCQB: EMED) Devices Offer FDA Cleared Treatment For Acute Pain

A new study of 580 participants in a Toronto-based study, as reported by Practical Pain Management (PPM) Magazine, finds that medical cannabis is one alternative to opioid-addicting pain killer [...]

READ MORE
COVID-19 Pandemic Drives Innovative Need For More Telemedicine And Remote Control Devices To Support Strained Medical Staff Who Need Greater Ability To Treat More Patients; Electromedical Technologies, Inc.’s (OTCQB: EMED) Devices Offer Relief For Patients With Chronic And Acute Pain
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

COVID-19 Pandemic Drives Innovative Need For More Telemedicine And Remote Control Devices To Support Strained Medical Staff Who Need Greater Ability To Treat More Patients; Electromedical Technologies, Inc.’s (OTCQB: EMED) Devices Offer Relief For Patients With Chronic And Acute Pain

Hospital medical staffs are so overwhelmed by the newest spike in the COVID-19 pandemic, they say they will not have time for RNs (registered nurses) and even doctor’s advocates to inject masses [...]

READ MORE
Remote Control Monitoring For Medical Devices Trending In COVID-19 For Non-Invasive Treatment; Electromedical Technologies, Inc. (OTCQB: EMED) Leads As EMED’s WellnessPlus POD With Remote Monitoring Portal Will Provide Relief From Chronic And Acute Pain
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

Remote Control Monitoring For Medical Devices Trending In COVID-19 For Non-Invasive Treatment; Electromedical Technologies, Inc. (OTCQB: EMED) Leads As EMED’s WellnessPlus POD With Remote Monitoring Portal Will Provide Relief From Chronic And Acute Pain

Remote control and non-invasive medical device treatment is trending in COVID-19 and Electromedical Technologies, Inc.’s (OTCQB: EMED) highly anticipated WellnessPlus POD is designed to deliver [...]

READ MORE
Remote Control Monitoring For Medical Devices Trending In COVID-19 For Non-Invasive Treatment; Electromedical Technologies, Inc. (OTCQB: EMED) Leads As EMED’s WellnessPlus POD With Remote Monitoring Portal Will Provide Relief From Chronic And Acute Pain
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

Remote Control Monitoring For Medical Devices Trending In COVID-19 For Non-Invasive Treatment; Electromedical Technologies, Inc. (OTCQB: EMED) Leads As EMED’s WellnessPlus POD With Remote Monitoring Portal Will Provide Relief From Chronic And Acute Pain

Remote control and non-invasive medical device treatment is trending in COVID-19 and Electromedical Technologies, Inc.’s (OTCQB: EMED) highly anticipated WellnessPlus POD is designed to deliver [...]

READ MORE
2021 And 2022 Projected To Be Boom Years For Electromedical Technologies, Inc. (OTCQB: EMED) As Volume Seen Reaching $17+ Million In Market For The Bioelectronics Industry Treating Chronic And Acute Pain With Its WellnessPro Plus Device And WellnessPlus POD
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

2021 And 2022 Projected To Be Boom Years For Electromedical Technologies, Inc. (OTCQB: EMED) As Volume Seen Reaching $17+ Million In Market For The Bioelectronics Industry Treating Chronic And Acute Pain With Its WellnessPro Plus Device And WellnessPlus POD

2021 and 2022 may be boom years for Electromedical Technologies, Inc. (OTCQB: EMED) if analyst Goldman Small Cap Research is right about the growth of the bioelectronics and neuromodulation [...]

READ MORE
Electromedical Technologies, Inc. (OTCQB: EMED) Seen As Poised To Emerge As A Leader In The Bioelectronics Industry For The Treatment Of Chronic And Acute Pain With Its FDA Cleared WellnessPro Plus Device, According To New Research Report Bullish On Future WellnessPlus POD And Its Remote Monitoring Portal
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

Electromedical Technologies, Inc. (OTCQB: EMED) Seen As Poised To Emerge As A Leader In The Bioelectronics Industry For The Treatment Of Chronic And Acute Pain With Its FDA Cleared WellnessPro Plus Device, According To New Research Report Bullish On Future WellnessPlus POD And Its Remote Monitoring Portal

Electromedical Technologies, Inc. (OTCQB: EMED) is seen as poised to emerge as a leader In the bioelectronics industry for the treatment of chronic and acute pain with its FDA cleared [...]

READ MORE
Word-Of-Mouth A Key Marketing Tool For Electromedical Technologies, Inc. (OTCQB: EMED) For Its FDA Cleared WellnessPro+ Device Which Relieves Chronic Pain Through Bioelectronics; EMED Spends $4.2 Million As It Builds 1,200+ Unit Inventory In Preparation For Attracting Hundreds More Medical Practitioners And Distributors In 2021
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

Word-Of-Mouth A Key Marketing Tool For Electromedical Technologies, Inc. (OTCQB: EMED) For Its FDA Cleared WellnessPro+ Device Which Relieves Chronic Pain Through Bioelectronics; EMED Spends $4.2 Million As It Builds 1,200+ Unit Inventory In Preparation For Attracting Hundreds More Medical Practitioners And Distributors In 2021

Word-Of-Mouth is one of the oldest and successful marketing tools and Matthew Wolfson, founder and CEO of Electromedical Technologies, Inc. (OTCQB: EMED) believes that it will add to sales via [...]

READ MORE
In Preparation For Its Strategic Plan Of Attracting Hundreds More Medical Practitioners And Distributors To Its Bioelectronic Devices Designed To Relieve Chronic And Acute Pain, Electromedical Technologies, Inc. (OTCQB: EMED) Has Invested $4.2 Million To Build More Than 1,200 Units, Including The FDA Cleared WellnessPro+ Device
By
In NASDAQ: AXSM, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, NYSE: TBA, OTCQB: EMED
Posted

In Preparation For Its Strategic Plan Of Attracting Hundreds More Medical Practitioners And Distributors To Its Bioelectronic Devices Designed To Relieve Chronic And Acute Pain, Electromedical Technologies, Inc. (OTCQB: EMED) Has Invested $4.2 Million To Build More Than 1,200 Units, Including The FDA Cleared WellnessPro+ Device

In Preparation For Its Strategic Plan Of Attracting Hundreds More Medical Practitioners And Distributors To Its Bioelectronic Devices Designed To Relieve Chronic And Acute Pain, Electromedical [...]

READ MORE
1 2 3
page 1 of 3